China’s Sinopharm CNBG looks to increase jabs to COVAX

CGTN published this video item, entitled “China’s Sinopharm CNBG looks to increase jabs to COVAX” – below is their description.

For more:

https://news.cgtn.com/news/2021-06-08/China-s-Sinopharm-CNBG-looks-to-increase-jabs-to-COVAX–10VV1XqD8Wc/index.html

China’s Sinopharm has already rolled out its first batch of COVID-19 vaccines to COVAX, a global initiative aimed to make doses more accessible to poorer countries. Now, the company is in talks to expand supplies. What are the company’s production plans for the future? Will it be challenging for China National Biotec Group (CNBG) to guarantee supplies domestically while making supplies for COVAX? CGTN’s Liu Yang spoke to one of the Sinopharm executives to find these answers.

CGTN YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

  • Children 5-12 may be eligible for Pfizer soon | Coronavirus | 9 News Australia
  • NSW Health apologises over home isolation clearance delays | 7.30
  • NSW Coronavirus Update – Wednesday 22nd September 2021 | 7NEWS
  • Melbourne tremors may continue, Victoria records 628 COVID-19 cases | 9 News Australia
  • NBC Nightly News Full Broadcast – September 21st, 2021
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • First batch of Chinese vaccines arrive in Kenya
  • China’s Sinopharm debuts new vaccines targeting COVID-19 variants
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.